Vetmedin 5 mg Flavoured Chewable Tablets for Dogs

Land: New Zealand

Sprog: engelsk

Kilde: Ministry for Primary Industries

Aktiv bestanddel:

pimobendan; pimobendan

Tilgængelig fra:

Boehringer Ingelheim Animal Health New Zealand Limited

Sammensætning:

pimobendan 100 g/kg; pimobendan 62.5 g/kg

Terapeutisk område:

Cardiovascular agent

Autorisation status:

ACVM Registered

Autorisation dato:

2018-05-01

Produktets egenskaber

Product: Vetmedin 5 mg Flavoured Chewable Tablets for Dogs
Date: 5 Feb 20219
Aug 2018
ACVM No.: A011513
Page 1 of 6
Page 1 of 6
Blister Pack
FOR ANIMAL TREATMENT ONLY
VETMEDIN
® 5 MG FLAVOURED CHEWABLE TABLETS FOR DOGS
EACH TABLET CONTAINS 5 MG PIMOBENDAN
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
78 Waterloo Road
North Ryde NSW 2113
Phone: [phone]
NEW ZEALAND INFO
RVM
ACVM No. A011513
Boehringer Ingelheim Animal Health New Zealand Ltd.
Freephone: 0800 800 822
Batch No.:
Expiry Date:
Product: Vetmedin 5 mg Flavoured Chewable Tablets for Dogs
Date: 5 Feb 20219
Aug 2018
ACVM No.: A011513
Page 2 of 6
Page 2 of 6
Folding Box Label
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
VETMEDIN
® 5 MG FLAVOURED
CHEWABLE TABLETS FOR DOGS
EACH TABLET CONTAINS 5 MG PIMOBENDAN
50 TABLETS
Vetmedin
®
Flavoured Chewable Tablets for Dogs are indicated for:
The treatment of canine congestive heart failure (CHF) originating
from dilated
cardiomyopathy (DCM) or valvular insufficiency (mitral and/or
tricuspid regurgitation).
The treatment of preclinical DCM in large breed dogs. When used in
cases of preclinical DCM
in large breed dogs, pimobendan significantly prolonged the time to
the onset of CHF or
sudden death, and also resulted in prolongation of the time to death
due to all causes.
Doberman Pinscher dogs with preclinical DCM treated with pimobendan
also demonstrated a
significant reduction in Left Ventricular Internal Diameter in both
systole and diastole
(LVIDs/d) in response to therapy.
For the treatment of dogs with evidence of increased heart size
secondary to asymptomatic
(preclinical) myxomatous mitral valve disease to delay the onset of
clinical symptoms of heart
failure, to reduce heart size and to increase survival time.
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS
DIRECTIONS FOR USE
DOSAGE AND ADMINISTRATION
Vetmedin
®
Chewable Tablets should be administered orally at a dose range of 0.1
– 0.3 mg
pimobendan /kg bodyweight twice daily. The ideal dose is 0.25 mg